Kontafarma China Holdings Limited (HKG:1312)
Hong Kong · Delayed Price · Currency is HKD 0.0280
0.00 (0.00%)
Jul 13, 2026, 3:17 PM HKT
Kontafarma China Holdings Market Cap
Kontafarma China Holdings has a market cap or net worth of 156.48 million as of July 10, 2026. Its market cap has increased by 7.69% in one year.
Market Cap
156.48M
Enterprise Value
217.09M
Revenue
914.71M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.03
Market Cap Chart
Since January 18, 2012, Kontafarma China Holdings's market cap has decreased from 719.40M to 156.48M, a decrease of -78.25%. That is a compound annual growth rate of -9.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 156.48M | -3.45% |
| Dec 31, 2025 | 162.07M | 11.54% |
| Dec 31, 2024 | 145.30M | -27.78% |
| Dec 29, 2023 | 201.19M | -20.00% |
| Dec 30, 2022 | 251.49M | -8.16% |
| Dec 31, 2021 | 273.84M | -43.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lee's Pharmaceutical Holdings | 630.05M |
| Zhongzhi Pharmaceutical Holdings | 595.88M |
| China NT Pharma Group Company | 398.58M |
| Wai Yuen Tong Medicine Holdings | 323.17M |
| Regent Pacific Group | 274.31M |
| Shenzhen Neptunus Interlong Bio-technique Company | 204.72M |
| Extrawell Pharmaceutical Holdings | 203.00M |
| Tianda Pharmaceuticals | 197.80M |